title: Relationship between Helicobacter pylori iceA, cagA, and vacA status and clinical outcome: studies in four different countries.
abstract: There is continuing interest in identifying Helicobacter pylori virulence factors that might predict the risk for symptomatic clinical outcomes. It has been proposed that iceA and cagA genes are such markers and can identify patients with peptic ulcers. We compared H. pylori isolates from four countries, looking at the cagA and vacA genotypes, iceA alleles, and presentation of the infection. We used PCR to examine iceA, vacA, and cagA status of 424 H. pylori isolates obtained from patients with different clinical presentations (peptic ulcer, gastric cancer, and atrophic gastritis). The H. pylori isolates examined included 107 strains from Bogota, Colombia, 70 from Houston, Tex., 135 from Seoul, Korea, and 112 from Kyoto, Japan. The predominant genotype differed among countries: the cagA-positive iceA1 vacA s1c-m1 genotype was predominant in Japan and Korea, the cagA-positive iceA2 vacA s1b-m1 genotype was predominant in the United States, and the cagA-positive iceA2 vacA s1a-m1 genotype was predominant in Colombia. There was no association between the iceA, vacA, or cagA status and clinical outcome in patients in the countries studied. iceA status shows considerable geographic differences, and neither iceA nor combinations of iceA, vacA, and cagA were helpful in predicting the clinical presentation of an H. pylori infection.
authors.affiliation: Veterans Affairs Medical Center and Baylor College of Medicine, Houston, Texas 77030, USA. yoshio@wt.net
authors.forename: Y
authors.initials: Y
authors.lastname: Yamaoka
authors.forename: T
authors.initials: T
authors.lastname: Kodama
authors.forename: O
authors.initials: O
authors.lastname: Gutierrez
authors.forename: J G
authors.initials: JG
authors.lastname: Kim
authors.forename: K
authors.initials: K
authors.lastname: Kashima
authors.forename: D Y
authors.initials: DY
authors.lastname: Graham
mesh_terms: D000942:Antigens, Bacterial; D001284:Atrophy; D001425:Bacterial Outer Membrane Proteins / Q000235:genetics*; D001426:Bacterial Proteins / Q000235:genetics*; D003105:Colombia; D005260:Female; D005753:Gastric Mucosa / Q000382:microbiology / Q000473:pathology; D005756:Gastritis / Q000382:microbiology / Q000473:pathology; D005838:Genotype; D016481:Helicobacter Infections / Q000150:complications / Q000503:physiopathology*; D016480:Helicobacter pylori / Q000235:genetics / Q000302:isolation & purification; D006801:Humans; D007564:Japan; D007723:Korea; D008297:Male; D008875:Middle Aged; D010437:Peptic Ulcer / Q000382:microbiology / Q000473:pathology; D011237:Predictive Value of Tests; D013274:Stomach Neoplasms / Q000382:microbiology / Q000473:pathology; D016896:Treatment Outcome; D014481:United States
chemical_list: D000942:Antigens, Bacterial; D001425:Bacterial Outer Membrane Proteins; D001426:Bacterial Proteins; C074689:VacA protein, Helicobacter pylori; C080866:cagA protein, Helicobacter pylori; C063113:ice nucleation protein